What is an appropriate taper and initiation schedule to switch a patient from escitalopram (Lexapro) 10 mg daily to sertraline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Escitalopram 10 mg to Sertraline

Taper escitalopram 10 mg over 10-14 days, then start sertraline 25-50 mg daily after completing the taper, avoiding any washout period between medications.

Recommended Switching Schedule

Escitalopram Taper (Days 1-14)

  • Gradual dose reduction over 10-14 days is recommended to minimize discontinuation symptoms 1, 2
  • The FDA label for Lexapro specifically states that "a gradual reduction in the dose rather than abrupt cessation is recommended whenever possible" 2
  • Suggested taper schedule:
    • Days 1-7: Reduce to 5 mg daily
    • Days 8-14: Discontinue completely
  • Monitor closely for discontinuation symptoms including dizziness, fatigue, headaches, nausea, anxiety, irritability, and sensory disturbances 1

Sertraline Initiation (Day 15)

  • Start sertraline 25-50 mg daily immediately after completing the escitalopram taper 1
  • No washout period is necessary when switching between SSRIs, as both escitalopram and sertraline have relatively short half-lives 1
  • The initial dose of 25-50 mg is well-tolerated and allows for assessment of response 1

Sertraline Titration

  • Increase sertraline by 25-50 mg every 1-2 weeks as tolerated 1
  • Target therapeutic dose is typically 50-200 mg daily 1
  • Most patients respond to 100-150 mg daily 3, 4
  • Maximum dose is 200 mg daily 1, 3

Important Clinical Considerations

Why This Approach is Preferred

  • Direct cross-taper is not necessary between these two SSRIs because they have similar mechanisms of action and relatively short half-lives 1
  • Escitalopram and sertraline have comparable efficacy for depression and anxiety, with no significant differences in treatment outcomes 1, 4
  • Both medications have similar adverse effect profiles, though sertraline may have slightly fewer drug-drug interactions than escitalopram 1

Monitoring Requirements

  • Assess patient status within 1-2 weeks of starting sertraline to monitor for therapeutic response and adverse effects 1
  • Continue monitoring regularly, especially during the first 1-2 months when risk of suicidal thoughts may be elevated 1
  • Watch for emergence of agitation, irritability, or unusual behavioral changes 1

Common Pitfalls to Avoid

  • Do not use alternate-day dosing during the taper, as this creates significant fluctuations in drug levels and increases withdrawal symptom risk 5
  • Do not abruptly discontinue escitalopram, as this substantially increases the risk of discontinuation syndrome 1, 2
  • Do not extend the washout period unnecessarily, as this leaves the patient untreated and risks clinical deterioration 6
  • If intolerable withdrawal symptoms occur during taper, resume the previous dose and taper more gradually 2

Dose Equivalence Context

  • Escitalopram 10 mg is approximately equivalent to sertraline 55 mg based on dose-equivalence studies 7
  • However, starting sertraline at 25-50 mg and titrating upward is the standard approach regardless of the previous escitalopram dose 1, 3
  • Most patients will require 100-150 mg sertraline for optimal therapeutic effect 3, 4

Special Populations

  • Elderly patients or those with hepatic impairment: Use more conservative tapering (extend to 2-3 weeks) and start sertraline at 25 mg daily 1, 2
  • Patients with history of severe discontinuation symptoms: Consider even slower taper over 3-4 weeks 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.